TY - CHAP M1 - Book, Section TI - Miller Fisher Syndrome A1 - Bissonnette, Bruno A1 - Luginbuehl, Igor A1 - Marciniak, Bruno A1 - Dalens, Bernard J. Y1 - 2006 N1 - T2 - Syndromes: Rapid Recognition and Perioperative Implications AB - Rare, acquired nerve disease considered to be a variant of Guillain-Barré syndrome. It is characterized by abnormal muscle coordination, ophthalmoplegia, and tendon areflexia. As with Guillain-Barré syndrome, the symptoms may be preceded by a viral illness. Other clinical features include generalized muscle weakness and respiratory failure. The prognosis is good, with recovery beginning within 2 to 4 weeks and almost completed within 6 months. Residual neurologic deficits may occur, and relapses occur in less than 3% of individuals affected. The majority of individuals with Miller Fisher syndrome have a unique antibody that characterizes the disorder. SN - PB - The McGraw-Hill Companies CY - New York, NY Y2 - 2024/03/29 UR - accessanesthesiology.mhmedical.com/content.aspx?aid=58076196 ER -